Abstract
Introduction The prevalence of frailty is on the rise with the aging population and increasing life expectancy, which often is accompanied by comorbidities. Frailty can be effectively detected using Frailty index such as KCL index. Early detection of frailty allows applying measures that reduce the conversion rate to frail, and improve the quality of life in the frail people. Therefore, to facilitate the screening of frailty status at the primary care level, we suggest to produce a shorter version of the KCL questionnaire.
Aim To understand the importance of KCL components in the decision making process for frailty and use machine learning approach to shorten the Questionnaire while maintaining reasonable accuracy, making it easier to screen for frailty in primary care.
Methods We developed an automated framework of three steps: Feature importance determination using Shap values, testing models with Cross-validation with increased addition of selected features. Moreover, we validated the reliability of KCL to detect frailty by comparing the results of KCL criteria with the unsupervised clustering of the data.
Results Our approach allowed us to identify the most important questions in the KCL questionnaire and demonstrate its performance using a short version with only four questions (4) Do you visit homes of friends?, (6) Are you able to go upstairs without using handrails or the wall for support? (10) Do you feel anxious about falling when you walk?, and (25) (In the past two weeks) Have you felt exhausted for no apparent reason?). We also showed that the data clustering corresponds well with the results of KCL criteria.
Discussion and Conclusion While it is difficult to predict pre-frail status using shorter KCL questionnaire, it was shown to be fairly accurate in predicting frail status using only four questions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is supported by: Japan Science and Technology Agency: COI-NEXT(grant number JPMJPF2018 to M.A.)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Watanabe, D., Yoshida, T., Nakagata, T. et al. Factors associated with sarcopenia screened by finger-circle test among middle-aged and older adults: a population-based multisite cross-sectional survey in Japan. BMC Public Health 21, 798 (2021). https://doi.org/10.1186/s12889-021-10844-3
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
